GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 180 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q1 2018. The put-call ratio across all filers is 0.55 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $389,000 | -77.7% | 7,400 | -77.5% | 0.03% | -66.7% |
| Q1 2019 | $1,741,000 | -62.5% | 32,900 | -65.8% | 0.08% | -72.7% |
| Q1 2018 | $4,646,000 | +550.7% | 96,200 | +318.3% | 0.30% | +681.6% |
| Q3 2017 | $714,000 | +13.5% | 23,000 | 0.0% | 0.04% | -2.6% |
| Q2 2017 | $629,000 | +50.1% | 23,000 | -20.7% | 0.04% | +14.7% |
| Q4 2016 | $419,000 | -71.8% | 29,000 | -55.0% | 0.03% | -71.7% |
| Q3 2016 | $1,484,000 | -41.9% | 64,400 | -58.2% | 0.12% | -49.8% |
| Q2 2016 | $2,554,000 | +77.9% | 154,000 | +70.0% | 0.24% | +64.8% |
| Q1 2016 | $1,436,000 | +0.8% | 90,600 | +105.4% | 0.14% | -20.3% |
| Q4 2015 | $1,425,000 | – | 44,100 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Logos Global Management LP | 850,000 | $46,869,000 | 6.00% |
| Asymmetry Capital Management, L.P. | 155,232 | $8,559,000 | 5.50% |
| Grace Capital | 124,749 | $6,878,000 | 5.33% |
| Fernwood Investment Management, LLC | 187,477 | $10,337,000 | 4.88% |
| Perceptive Advisors | 5,800,996 | $319,867,000 | 4.67% |
| ArchPoint Investors | 217,510 | $11,993,000 | 3.83% |
| GREAT POINT PARTNERS LLC | 655,676 | $36,154,000 | 3.25% |
| Profit Investment Management, LLC | 42,196 | $2,328,000 | 1.44% |
| Bain Capital Public Equity Management II, LLC | 381,868 | $21,056,000 | 1.39% |
| Taylor Wealth Management Partners | 52,597 | $2,900,000 | 1.33% |